Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments

Eur Heart J. 2011 Aug;32(15):1832-4. doi: 10.1093/eurheartj/ehr019. Epub 2011 Apr 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Angiopathies / mortality*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / analogs & derivatives*
  • Metformin / therapeutic use*
  • Myocardial Infarction / mortality*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Metformin